OpenNashPodcasts

Topic

COVID-19

12 facts from 7 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

2003

Kyle Harper says SARS-CoV-1 in 2003 was slightly more virulent and made people sick quickly, which made it easier to contain than COVID-19.

“Like the first COVID, SARS-CoV-1, 2003, slightly more virulent. And in fact, it was just more virulent enough that it made you sick pretty quick.”

Kyle Harper · Why Rome actually fell: plagues, slavery, & ice age — Kyle Harper, 1:14:52

2020

Andrew von Eschenbach says monoclonal antibodies could be developed from antibodies made by people who have recovered from the coronavirus.

“develop monoclonal antibodies by finding people who have conquered the virus, have already made an antibody within their own system to destroy or fight off that virus.”

Andrew von Eschenbach · Ep. 8: Legacy, with former FDA Commissioner Andrew von Eschenbach, 0:06:27

2020

Shah says Washington State had the first COVID-19 case in the continental United States, along with the first outbreak and first death.

“this was the state that had the first case in the continental United States, had the first outbreak and the first death.”

Umair Shah · Reimagining healthcare delivery and public health with AI, 0:08:21

2020

Peter Lee asked whether the first U.S. COVID-19 patient was detected through the Seattle Flu Study's surveillance, and Shah agreed.

“wasn't a patient number one in the united states discovered also because of the seattle flu study or at least that sort of syndromic surveillance”

Umair Shah · Reimagining healthcare delivery and public health with AI, 0:30:01

Undated

Amy Abernethy says the COVID-19 genome was sequenced and published for scientists worldwide within 24 hours, which enabled rapid mRNA vaccine development.

“essentially sequencing the genome, publishing it for scientists all around the world to use within 24 hours, and then moving from there.”

Amy Abernethy · AI, Innovation, and Regulatory Insights with Amy Abernethy, 0:03:04

Undated

Amy Abernethy says data from Israel's health systems was used to study how long COVID-19 vaccine effectiveness lasts, safety signals and the need for boosters.

“we leveraged, for example, data from the Israel health systems to understand duration of effectiveness and safety signals and do you need a booster.”

Amy Abernethy · AI, Innovation, and Regulatory Insights with Amy Abernethy, 0:03:35

Episodes